Modeling Combinations of Antiretroviral Agents in Vitro With Integration of Pharmacokinetics: Guidance in Regimen Choice for Clinical Trial Evaluation.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.40.5.1143
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Optimal Choice of Antiretroviral Therapy Regimen Including Phospha

Archiv Euromedica
2020English

Clinical Pharmacology of Gentamicin in Neonates: Regimen, Toxicology and Pharmacokinetics

Medical Express
2015English

Epistemic Games in Integration: Modeling Resource Choice

2007English

In Vitro Pharmacokinetics/Pharmacodynamics Evaluation of Marbofloxacin Against Staphylococcus Pseudintermedius

Veterinarni Medicina
Veterinary
2020English

Cell:to:ECG Modeling and Clinical Trial ECG Evaluation of ECG J:to:Tpeak Interval

2016English

Raltegravir in Combination With Other Antiretroviral Agents for the Treatment of HIV Infection

Infection and Drug Resistance
Infectious DiseasesPharmacology
2010English

Cellular Modeling of Cancer Invasion: Integration of in Silico and in Vitro Approaches

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2011English

Resistance of Clinical Isolates of Human Immunodeficiency Virus to Antiretroviral Agents.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1993English

Proof of Concept to Clinical Confirmation: Evolving Clinical Trial Designs for Targeted Agents

ISRN Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy